Helix has introduced Whole Exome+ Sequencing, a single-order assay that combines exome, mitochondrial, and digital karyotype analysis, with 99% coverage of clinically relevant regions.
Medicare has expanded coverage for NeoGenomics’ RaDaR ST MRD assay to include monitoring immunotherapy response in patients with late-stage solid tumors.
ADLM 2026 drew nearly 17,000 professionals to Anaheim, where experts discussed advances in space diagnostics, mass spectrometry, and chronic disease management, and Kompass Diagnostics won the Disruptive Technology Award for its IDA platform.
ProtaGene’s Heidelberg, Germany, lab has received CAP and CLIA accreditation, authorizing integration site analysis on human samples for lentivirus-based cell and gene therapy under U.S. federal regulations.
Docus unveiled an AI platform for diagnostic laboratories at ADLM 2026, offering interpretation, follow-up, and compliance features that integrate with existing LIS via API or HL7.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The strategic alliance will leverage de-identified laboratory data to support quality improvement across 1,526 community health centers and includes a leadership exchange program for chief medical officers.
Position your laboratory for the future of hemostasis testing This sponsored white paper explores how advances in automation, workflow optimization, and intelligent coagulation analysis are helping laboratories improve...